Escherichia coli as a sentinel in the assessment of antimicrobial resistance in the tilapia production chain: from production environment to the final product.

Frontiers in antibiotics Pub Date : 2024-10-22 eCollection Date: 2024-01-01 DOI:10.3389/frabi.2024.1461662
Sthéfany Da Cunha Dias, Letícia Roberta Martins Costa, Ana Beatriz Garcez Buiatte, Marcus Vinícius Coutinho Cossi, Luís Augusto Nero, Ricardo Seiti Yamatogi, Luciano Dos Santos Bersot, Juliano Gonçalves Pereira
{"title":"<i>Escherichia coli</i> as a sentinel in the assessment of antimicrobial resistance in the tilapia production chain: from production environment to the final product.","authors":"Sthéfany Da Cunha Dias, Letícia Roberta Martins Costa, Ana Beatriz Garcez Buiatte, Marcus Vinícius Coutinho Cossi, Luís Augusto Nero, Ricardo Seiti Yamatogi, Luciano Dos Santos Bersot, Juliano Gonçalves Pereira","doi":"10.3389/frabi.2024.1461662","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The intensification of tilapia production has increased animal density in tanks, leading to more frequent exposure to pathogenic agents and compromising the quality of fish products. Antimicrobial resistance is a global concern that affects human treatment, and sentinel microorganisms like <i>Escherichia coli</i> are crucial for monitoring production chains, especially in aquaculture, where research is still limited. The aim of this study was to identify the presence of <i>E. coli</i> and investigate its antimicrobial resistance profiles throughout the entire tilapia production chain.</p><p><strong>Methods: </strong>A total of 240 samples were collected from various points in the production process: carcasses before scaling (Ca), scaling wastewater (Sw), filleting wastewater (Fw), fillet washing wastewater (Tw), fillet handling surfaces (Su), and pre-packaged fillets (Pf). The samples were collected during 10 visits, each corresponding to animals from different farms. <i>E. coli</i> isolates were identified using MacConkey agar and biochemical tests. Phenotypic resistance profiles were determined using nine classes of antimicrobials. Extended- spectrum b-lactamase (ESBL) production was identified with ceftazidime and cefotaxime and confirmed by a double-disc synergy test. Isolates were classified as sensitive or resistant based on the inhibition zone. Multidrug-resistant (MDR) was defined as resistance to at least one agent in three or more antimicrobial categories, while extensively drug-resistant (XDR) was defined as resistance to at least one agent in all but two or fewer categories.</p><p><strong>Results: </strong>Overall, 50.8% of the samples (122/240) tested positive for <i>E. coli</i>, with 403 isolates identified. Of these, 33% (133/403) were resistant to at least two antimicrobials, and 20% (48/240) of the samples had MDR isolates, with the highest frequency found at the filleting point (Fw), which also had the only XDR profile. Resistance was most commonly observed against amoxicillin (35.73%), tetracycline (30.77%), and ciprofloxacin (26.30%).</p><p><strong>Discussion: </strong>These findings emphasize the importance of <i>E. coli</i> as an indicator of antimicrobial resistance throughout tilapia processing and highlight the need for good production practices and qualified technical support to mitigate risks to public health, animal health, and the environment.</p>","PeriodicalId":73065,"journal":{"name":"Frontiers in antibiotics","volume":"3 ","pages":"1461662"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11731651/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in antibiotics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/frabi.2024.1461662","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The intensification of tilapia production has increased animal density in tanks, leading to more frequent exposure to pathogenic agents and compromising the quality of fish products. Antimicrobial resistance is a global concern that affects human treatment, and sentinel microorganisms like Escherichia coli are crucial for monitoring production chains, especially in aquaculture, where research is still limited. The aim of this study was to identify the presence of E. coli and investigate its antimicrobial resistance profiles throughout the entire tilapia production chain.

Methods: A total of 240 samples were collected from various points in the production process: carcasses before scaling (Ca), scaling wastewater (Sw), filleting wastewater (Fw), fillet washing wastewater (Tw), fillet handling surfaces (Su), and pre-packaged fillets (Pf). The samples were collected during 10 visits, each corresponding to animals from different farms. E. coli isolates were identified using MacConkey agar and biochemical tests. Phenotypic resistance profiles were determined using nine classes of antimicrobials. Extended- spectrum b-lactamase (ESBL) production was identified with ceftazidime and cefotaxime and confirmed by a double-disc synergy test. Isolates were classified as sensitive or resistant based on the inhibition zone. Multidrug-resistant (MDR) was defined as resistance to at least one agent in three or more antimicrobial categories, while extensively drug-resistant (XDR) was defined as resistance to at least one agent in all but two or fewer categories.

Results: Overall, 50.8% of the samples (122/240) tested positive for E. coli, with 403 isolates identified. Of these, 33% (133/403) were resistant to at least two antimicrobials, and 20% (48/240) of the samples had MDR isolates, with the highest frequency found at the filleting point (Fw), which also had the only XDR profile. Resistance was most commonly observed against amoxicillin (35.73%), tetracycline (30.77%), and ciprofloxacin (26.30%).

Discussion: These findings emphasize the importance of E. coli as an indicator of antimicrobial resistance throughout tilapia processing and highlight the need for good production practices and qualified technical support to mitigate risks to public health, animal health, and the environment.

在罗非鱼生产链中:从生产环境到最终产品的抗菌素耐药性评估中,大肠杆菌作为哨兵。
导言:罗非鱼生产的集约化增加了鱼缸中的动物密度,导致更频繁地暴露于病原体并损害鱼产品的质量。抗菌素耐药性是一个影响人类治疗的全球性问题,大肠杆菌等哨点微生物对于监测生产链至关重要,特别是在水产养殖领域,而水产养殖的研究仍然有限。本研究的目的是确定大肠杆菌的存在,并调查其在整个罗非鱼生产链中的抗微生物药物耐药性。方法:从生产过程的各个环节采集240份样品:鳞前胴体(Ca)、鳞废水(Sw)、鱼片废水(Fw)、鱼片洗涤废水(Tw)、鱼片处理表面(Su)和预包装鱼片(Pf)。样本在10次访问中收集,每次访问对应于来自不同农场的动物。采用麦康基琼脂和生化试验对大肠杆菌分离株进行鉴定。使用9类抗菌素测定表型耐药谱。用头孢他啶和头孢噻肟鉴定了广谱b-内酰胺酶(ESBL)的产生,并通过双盘协同试验证实。根据抑菌区将分离株分为敏感株和耐药株。多重耐药(MDR)被定义为对三种或更多种抗菌素类别中至少一种药物的耐药性,而广泛耐药(XDR)被定义为对除两种或更少类别外的所有类别中至少一种药物的耐药性。结果:总体而言,50.8%的样本(122/240)检测出大肠杆菌阳性,鉴定出403株。其中33%(133/403)的样本至少对两种抗菌素具有耐药性,20%(48/240)的样本有MDR分离株,在夹角点(Fw)发现的频率最高,这也是唯一的XDR谱。耐药率最高的是阿莫西林(35.73%)、四环素(30.77%)和环丙沙星(26.30%)。讨论:这些发现强调了大肠杆菌作为整个罗非鱼加工过程中抗微生物药物耐药性指标的重要性,并强调需要良好的生产规范和合格的技术支持,以减轻对公共卫生、动物卫生和环境的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信